- Changing Patterns of Antibiotic Resistance of Helicobacter pylori in Patients with Peptic Ulcer Disease
-
Rhie SY, Kim JG
- KMID: 937939
- Korean J Gastroenterol.
- 2007 Dec;50(6):407-409.
No abstract availble. -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of Metronidazole Resistance on Eradication Rate for Helicobacter pylori
-
Lee H, Kim JJ
- KMID: 1113437
- Korean J Gastroenterol.
- 2005 Aug;46(2):142-145.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Time to learn from the past and prepare for the future in Helicobacter pylori eradication
-
Bang CS, Baik GH
- KMID: 2381582
- Korean J Intern Med.
- 2015 Nov;30(6):789-791.
- doi: 10.3904/kjim.2015.30.6.789
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Antibiotic Resistance on the Eradication of Helicobacter pylori
-
Kim N
- KMID: 1079909
- Korean J Gastroenterol.
- 2006 Jan;47(1):82-86.
No abstract availble. -
- CITED
-
- Close
- SHARE
-
- Close
- New Therapeutic Strategies against Helicobacter pylori
-
Kang BK, Park SM, Kim BW
- KMID: 1730925
- Korean J Gastroenterol.
- 2014 Mar;63(3):146-150.
- doi: 10.4166/kjg.2014.63.3.146
The standard therapy for Helicobacter pylori infection in Korea is a triple-drug regimen consisting of a proton pump inhibitor with two antibiotics such as clarithromycin, amoxicillin, and metronidazole. However, as... -
- CITED
-
- Close
- SHARE
-
- Close
- Does Standard Triple Therapy Still Have a Role in First-Line Helicobacter pylori Eradication in Korea?
-
Jeon HK, Kim GH
- KMID: 1786099
- J Korean Med Sci.
- 2014 May;29(5):619-620.
- doi: 10.3346/jkms.2014.29.5.619
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Mucolytics as Adjuvant Agent to Improve Helicobacter pylori Eradication Rate: Still Long and Winding Road to Positive Results
-
Yoon H, Lee DH
- KMID: 2155633
- Gut Liver.
- 2015 May;9(3):257-258.
- doi: 10.5009/gnl15117
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- There Is No Reason to Delay Helicobacter pylori Eradication after Treatment for Upper Gastrointestinal Bleeding
-
Lee SY
- KMID: 2155634
- Gut Liver.
- 2015 May;9(3):259-260.
- doi: 10.5009/gnl14499
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Changes in the Eradication Rate of Conventional Triple Therapy for Helicobacter pylori Infection in Korea
-
Heo J, Jeon SW
- KMID: 1730924
- Korean J Gastroenterol.
- 2014 Mar;63(3):141-145.
- doi: 10.4166/kjg.2014.63.3.141
Although, the prevalence of Helicobacter pylori infection in Korea has declined owing to the eradication therapy, recent seroprevalence of H. pylori infection is still reported to be as high as... -
- CITED
-
- Close
- SHARE
-
- Close
- Does Helicobacter pylori Eradication Therapy Reduce the Risk of Developing Gastric Cancer in Healthy Asymtomatic Individuals?
-
Kim YJ, Chung WC
- KMID: 1791898
- Korean J Gastroenterol.
- 2014 Jul;64(1):62-65.
- doi: 10.4166/kjg.2014.64.1.62
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Decreased Eradication Rates of Helicobacter pylori and Problem Solving
-
Jo Y
- KMID: 1730912
- Korean J Gastroenterol.
- 2014 Feb;63(2):63-65.
- doi: 10.4166/kjg.2014.63.2.63
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Future Trends of Helicobacter pylori Eradication Therapy in Korea
-
Lee JY, Kim N
- KMID: 1730927
- Korean J Gastroenterol.
- 2014 Mar;63(3):158-170.
- doi: 10.4166/kjg.2014.63.3.158
The prevalence of Helicobacter pylori infection in Korea shows a decreasing trend and has changed to that of developed country, especially for those below 30 years old. However, the primary... -
- CITED
-
- Close
- SHARE
-
- Close
- Roadmap for elimination of gastric cancer in Korea
-
Graham DY
- KMID: 2160675
- Korean J Intern Med.
- 2015 Mar;30(2):133-139.
- doi: 10.3904/kjim.2015.30.2.133
Most gastric cancers are caused by infection with the common human bacterial pathogen, Helicobacter pylori. It is now accepted that gastric cancer can be prevented and virtually eliminated by H.... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of Helicobacter pylori Infection
-
Kim JG
- KMID: 935208
- Korean J Gastroenterol.
- 2005 Sep;46(3):172-180.
Significant progress and new insights have been gained since Helicobacter pylori was found in 1982. Even with currently most effective treatment regimen, about 10-20% of patients will fail to obtain... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Rifabutin- and Levofloxacin-based Third-line Rescue Therapies for Helicobacter pylori
-
Jeong MH, Chung JW, Lee SJ, Ha M, Jeong SH, Na S, Na BS, Park SK, Kim YJ, Kwon KA, Ko KI, Jo Y, Hahm KB, Jung HY
- KMID: 1792844
- Korean J Gastroenterol.
- 2012 Jun;59(6):401-406.
- doi: 10.4166/kjg.2012.59.6.401
BACKGROUND/AIMS: There is increasing need for third-line therapy of Helicobacter pylori due to increasing level of antibiotics resistance. The aim of this study was to compare rifabutin and levofloxacin rescue... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Two Triple Eradication Regimens in Children with Helicobacter pylori Infection
-
Choi J, Jang JY, Kim JS, Park HY, Choe YH, Kim KM
- KMID: 1713115
- J Korean Med Sci.
- 2006 Dec;21(6):1037-1040.
- doi: 10.3346/jkms.2006.21.6.1037
Triple therapy with bismuth subsalicylate, amoxicillin, metronidazole (BAM) or with omeprazole, amoxicillin, clarithromycin (OAC) has been commonly used for the eradication of Helicobacter pylori infection. We compared the efficacy of... -
- CITED
-
- Close
- SHARE
-
- Close
- The Efficacy of Levofloxacin Based Triple Therapy for Helicobacter pylori Eradication
-
Lee JH, Hong SP, Kwon CI, Phyun LH, Lee BS, Song HU, Ko KH, Hwang SG, Park PW, Rim KS, Ki S
- KMID: 782733
- Korean J Gastroenterol.
- 2006 Jul;48(1):19-24.
BACKGROUND/AIMS: The failure rates of first and second line therapies of Helicobacter pylori (H. pylori) eradication range from 15 to 20%. This study was aimed to evaluate the efficacy and... -
- CITED
-
- Close
- SHARE
-
- Close
- Clarithromycin-Based Standard Triple Therapy Can Still Be Effective for Helicobacter pylori Eradication in Some Parts of the Korea
-
Yoon KH, Park SW, Lee SW, Kim BJ, Kim JG
- KMID: 1794602
- J Korean Med Sci.
- 2014 Sep;29(9):1240-1246.
- doi: 10.3346/jkms.2014.29.9.1240
We evaluated the antibiotic resistance rates and eradication rates of clarithromycin based triple therapy from 2005 to 2010 retrospectively. In addition, we investigated the mechanism of clarithromycin resistance in Helicobacter... -
- CITED
-
- Close
- SHARE
-
- Close
- Ten-day Sequential Therapy versus Bismuth Based Quadruple Therapy as Second Line Treatment for Helicobacter pylori Infection
-
Kim SB, Lee SH, Kim KO, Jang BI, Kim TN
- KMID: 2373354
- Korean J Gastroenterol.
- 2015 Nov;66(5):261-267.
- doi: 10.4166/kjg.2015.66.5.261
BACKGROUND/AIMS: Ten-day sequential therapy has been evaluated as the first line therapy for Helicobacter pylori eradication but studies on sequential therapy as a second line therapy is lacking. The aim... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of N-acetylcysteine on First-Line Sequential Therapy for Helicobacter pylori Infection: A Randomized Controlled Pilot Trial
-
Yoon H, Lee DH, Jang ES, Kim J, Shin CM, Park YS, Hwang JH, Kim JW, Jeong SH, Kim N
- KMID: 2412038
- Gut Liver.
- 2016 Jul;10(4):520-525.
- doi: 10.5009/gnl15048
BACKGROUND/AIMS: To evaluate the adjuvant effects of N-acetylcysteine (NAC) on first-line sequential therapy (SQT) for Helicobacter pylori infection. METHODS: Patients with H. pylori infections were randomly assigned to receive sequential therapy... -
- CITED
-
- Close
- SHARE
-
- Close
